Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
561.55
+4.99 (0.90%)
At close: Aug 13, 2025, 4:00 PM
560.55
-1.00 (-0.18%)
After-hours: Aug 13, 2025, 7:58 PM EDT
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$808.43
Upside
+43.96%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $940 → $812 | Strong Buy | Maintains | $940 → $812 | +44.60% | Aug 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $600 → $640 | Buy | Maintains | $600 → $640 | +13.97% | Aug 4, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $754 → $761 | Buy | Maintains | $754 → $761 | +35.52% | Aug 4, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $688 → $695 | Hold | Maintains | $688 → $695 | +23.76% | Aug 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $810 → $815 | Strong Buy | Maintains | $810 → $815 | +45.13% | Aug 4, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $850 | Strong Buy | Maintains | $850 | +51.37% | Jul 23, 2025 |
| UBS | UBS | Hold Maintains $560 → $584 | Hold | Maintains | $560 → $584 | +4.00% | Jul 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $755 → $754 | Buy | Maintains | $755 → $754 | +34.27% | Jul 10, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $950 → $800 | Buy | Maintains | $950 → $800 | +42.46% | Jun 9, 2025 |
| UBS | UBS | Hold Maintains $633 → $560 | Hold | Maintains | $633 → $560 | -0.28% | Jun 5, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $700 → $650 | Strong Buy | Maintains | $700 → $650 | +15.75% | Jun 2, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $800 → $600 | Buy | Maintains | $800 → $600 | +6.85% | Jun 2, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $958 → $755 | Buy | Maintains | $958 → $755 | +34.45% | Jun 2, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $700 → $580 | Buy → Hold | Downgrades | $700 → $580 | +3.29% | May 30, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $943 | Buy | Reiterates | $943 | +67.93% | May 27, 2025 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $600 → $700 | Hold → Strong Buy | Upgrades | $600 → $700 | +24.65% | May 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.